# A Study to Evaluate the Efficacy of Cytal® Burn Matrix in the Management of Partial-Thickness Burns to the Hand

> **NCT03598023** · NA · WITHDRAWN · sponsor: **Integra LifeSciences Corporation**

## Conditions studied

- Partial Thickness Burn of Hand

## Interventions

- **DEVICE:** Cytal® Burn Matrix
- **DEVICE:** EZ-Derm® Porcine Xenograft

## Key facts

- **NCT ID:** NCT03598023
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor discretion
- **Last updated:** 2021-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03598023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03598023, "A Study to Evaluate the Efficacy of Cytal® Burn Matrix in the Management of Partial-Thickness Burns to the Hand". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT03598023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*